Maternal Tumours Associated with and Influenced by Pregnancy

  • György BerencsiIII


The blastocyte developes embryoblasts and trophoblasts. Cytotrophoblasts cover the whole embryo. Syncytiotrophoblasts will be induced by the products of human endogeneous retroviruses (HERV-W) causing membrane fusion of the cells, thus creating a continuous border between the maternal blood and the fetal circulation, feeding, detoxicating, and regulating its development. The immunological, regulatory, hormonal, etc. changes of the maternal body prevent the impairment of the fetus carrying the paternal haplotype, too.

Tumour cells and preneoplastic cells, however, are equally well tolerated by the mother as the fetus itself. Certain maternal tumours possess therefore an epidemiologically measurable peak among the age groups before 50 years of age. Other malignancies are stimulated by the hormonal changes of the pregnants. Others are not stimulated, but the reduced maternal immunological control enables enhanced multiplication of cells.

Trophoblasts possess similar growth properties to tumour cells. Tumours of trophoblast origin may appeare during pregnancy and threat the life of both the fetus and mother.

The immunological changes of the maternal immune system may increase the number of TREG cells, which might result in immunotolerance to certain tumour antigens extending even to the post partum life.

The exacerbating tumours imply different risks to the developping fetus. In addition to the direct impairment of the pregnancy, the maternal tumours have to be diagnosed, and in the majority of the patients also threated. All these medical interventions, even surgical operations have to be done using methodologies, which had been found previously harmless to the developping fetuses.

Maternal tumours can methastatise into the placenta and even into the fetal organs. These later consequences will be discussed in this chapter.


Breast Cancer Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Differentiate Thyroid Cancer Polycythemia Vera 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abadi U, Koren G, Lishner M (2011) Leukemia and lymphoma in pregnancy. Hematol Oncol Clin North Am 25:277–291, vii. ReviewPubMedGoogle Scholar
  2. ACOG Committee Opinion # 337 (2006) Noncontraceptive uses of levonorgestrel intrauterine device system. Obstet Gynecol 107:1479–82Google Scholar
  3. Adeniji BA, Fallas M, Incerpi M, Hamburg S, Katz R, Ogunyemi D (2010) Laparoscopic splenectomy for hairy cell leukemia in pregnancy. Case Report Med 2010(136823). doi: 10.1155/2010/136823
  4. Adini A, Kornaga T, Firoozbakht F, Benjamin LE (2002) Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 62:2749–2752PubMedGoogle Scholar
  5. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK (1999) Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 54:728–737. doi: 10.1097/00006254-199911000-00025 PubMedGoogle Scholar
  6. Ahlgren M, Melbye M, Wohlfahrt J, Sørensen TI (2004) Growth patterns and the risk of breast cancer in women. N Engl J Med 351:1619–1626. doi: 10.1056/NEJMoa040576 PubMedGoogle Scholar
  7. Al-Adnani M, Kiho L, Sceimberg I (2007) Maternal pancreatic carcinoma metastatic to the placenta: a case report and literature review. Pediatr Dev Pathol 10:61–65. doi: 10.2350/06-06-0119.1 PubMedGoogle Scholar
  8. Alexander A, Samlowsky WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, Noyes RD, Bowen GM, Leachman SA (2003) Metastatic melanoma in pregnancy: risk of transplacental metatstases in the infant. J Clin Oncol 21:2179–2186. doi: 10.1200/JCO.2003.12.149 PubMedGoogle Scholar
  9. Altan E, Arslan C, Dede D, Dogan E, Altundag K (2010) Primary angiosarcoma of the breast after pregnancy. Am Surg 76:E115PubMedGoogle Scholar
  10. Altaner C (2008) Glioblastoma and stem cells. Neoplasma 55:369–374. doi: 10.1016/j.canlet.2008.04.023 PubMedGoogle Scholar
  11. Alvares de la Rosa MA, Nicolas-Pérez D, Muńiz-Montes JR, Trujillo-Carrillo JL (2006) Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res 32:437–439Google Scholar
  12. Alves GV, Santin AP, Furlanetto TW (2011) Prognosis of thyroid cancer related to pregnancy: a systematic review. J Thyroid Res 2011:691719PubMedGoogle Scholar
  13. Amant F, Brepoels L, Halaska MJ, Gziri MM, Calsteren KV (2010) Gynaecologic cancer complicating pregnancy: an overview. Best Pract Res Clin Obstet Gynaecol 24:61–79. doi: 10.1016/j.bpobgyn.2009.08.001 PubMedGoogle Scholar
  14. Anatolian Medical Oncology Society Group, Ustaalioglu BB, Gumus M, Unal A, Cayir K, Sever O, Bilici A, Elkiran ET, Karaca H, Benekli M, Karaoglu A, Seker M (2010) Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences. Int J Gynecol Cancer 20:698–703, ReviewPubMedGoogle Scholar
  15. André M, Mounier N, Leleu X, Sonet A, Brice P, Henry-Amar M, Tilly H, Coiffier B, Bosly A, Morel P, Haioun C, Gaulard P, Reyes F, Gisselbrecht C, Groupe D'Etude Des Lymphomes De L’Adulte (2004) Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2,837 patients. Blood 103:1222–1228. doi: 10.1182/blood-2003-04-1124 PubMedGoogle Scholar
  16. Antic T, Perry KT, Harrison K, Zaytsev P, Pins M, Campbell SC, Picken MM (2006) Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med 130(1):80–85Google Scholar
  17. Antonelli NM, Dotters DJ, Katz VL, Kuller JA (1996a) Cancer in pregnancy: a review of the literature. Part II. Obstet Gynecol Surv 51:135–142, ReviewPubMedGoogle Scholar
  18. Antonelli NM, Dotters DJ, Katz VL, Kuller JA (1996b) Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv 51:125–134, ReviewPubMedGoogle Scholar
  19. Apperley J (2009) CML in pregnancy and childhood. Best Pract Res Clin Haematol 22:455–474. doi: 10.1016/j.beha.2009.09.008 PubMedGoogle Scholar
  20. Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173–177. doi: 10.3816/CLM.2001.n.023 PubMedGoogle Scholar
  21. Azim HA Jr, Peccatori FA (2011) Managing cancer during pregnancy: what evidence do we have? Pol Arch Med Wewn 121:29–34, ReviewPubMedGoogle Scholar
  22. Baker AM, Haeri S, Shafer A, Moldenhauer JS (2010) Maternal gastric carcinoma metastatic to the placenta. Eur J Obstet Gynecol Reprod Biol 153(2):225–226. doi: 10.1016/j.ejogrb.2010.07.018 PubMedGoogle Scholar
  23. Basta NO, James PW, Craft AW, McNally RJ (2011) Seasonal variation in the month of birth in teenagers and young adults with melanoma suggests the involvement of early-life UV exposure. Pigment Cell Melanoma Res 24:250–253. doi: 10.1111/j.1755-148X.2010.00791.x PubMedGoogle Scholar
  24. Bellik L, Vinci MC, Filippi S, Ledda F, Parenti A (2005) Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol 146:568–575. doi:10.1038/sj.bjp. 0706347PubMedGoogle Scholar
  25. Beni-Adani L, Pomeranz S, Flores I, Shoshan Y, Ginosar Y, Ben-Shachar I (2001) Huge acoustic neurinomas presenting in the late stage of pregnancy. Acta Obstet Gynecol Scand 80:179–184. doi: 10.1080/j.1600-0412.2001.080002179.x PubMedGoogle Scholar
  26. Bernardeschi P, Pirrotta MT (2010) Spontaneous regression of chronic myeloid leukemia during pregnancy. Acta Haematol 124:225–226. doi: 10.1159/000321495 PubMedGoogle Scholar
  27. Bernstein MA, Madoff RD, Caushaj PF (1993) Colon and rectal cancer in pregnancy. Dis Colon Rectum 36:172–178. doi: 10.1007/BF02051174 PubMedGoogle Scholar
  28. Bevier M, Sundquist J, Hemminki K (2011) Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? Eur J Cancer 47:586–591. doi: 10.1016/j.ejca.2010.10.004 PubMedGoogle Scholar
  29. Blackhall FH, Merry CL, Davies EJ, Jayson GC (2001) Heparan sulfate proteoglycans and cancer. Br J Cancer 85:1094–1098. doi: 10.1054/bjoc.2001.2054 PubMedGoogle Scholar
  30. Blumenthal DT, Parreño MG, Batten J, Chamberlain MC (2008) Management of malignant gliomas during pregnancy: a case series. Cancer 113:3349–3354. doi: 10.1002/cncr.23973 PubMedGoogle Scholar
  31. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17. doi: 10.1016/0090-8258(83)90111-7 PubMedGoogle Scholar
  32. Boyon C, Collinet P, Boulanger L, Vinatier D (2011) Is fetal microchimerism beneficial for the fetus or the mother. Gynecol Obstet Fertil 39:224–231. doi: 10.1016/j.gyobfe.2011.02.009, Review. FrenchPubMedGoogle Scholar
  33. Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184–1187. doi: 10.1093/jnci/djn211 PubMedGoogle Scholar
  34. Brown CM, Ahmad ZK, Ryan AF, Doherty JK (2011a) Estrogen receptor expression in sporadic vestibular schwannomas. Otol Neurotol 32:158–162. doi: 10.1097/MAO.0b013e3181feb92a PubMedGoogle Scholar
  35. Brown LM, Check DP, Devesa SS (2011b) Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control 22:753–763. doi: 10.1007/s10552-011-9748-1 PubMedGoogle Scholar
  36. Bryant AE, Genc M, Hurtado RM, Chen KT (2004) Pulmonary Kaposi’s sarcoma in pregnancy. Am J Perinatol 21:355–363. doi: 10.1055/s-2004-831880 PubMedGoogle Scholar
  37. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH (2011) Prospective evaluation of insulin resistance among endometrialcancer patients. Am J Obstet Gynecol 204:355.e1–7. doi: 10.1016/j.ajog.2010.11.033 Google Scholar
  38. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019–5032. doi: 10.1182/blood-2011-01-293050, ReviewPubMedGoogle Scholar
  39. Carletti MZ, Christenson LK (2009) MicroRNA in the ovary and female reproductive tract. J Anim Sci 87:E29–E38. doi: 10.2527/jas.2008-1331 PubMedGoogle Scholar
  40. Catlin EA, Roberts JD Jr, Erana R, Preffer FI, Ferry JA, Kelliher AS, Atkins L, Weinstein HJ (1999) Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med 341:85–91. doi: 10.1056/NEJM199907083410204 PubMedGoogle Scholar
  41. Chang CC, Chen CC, Chiu HF, Yang CY (2011) Higher parity associated with higher risk of death from gastric cancer. World J Gastroenterol 17:784–788. doi: 10.3748/wjg.v17.i6.784 PubMedGoogle Scholar
  42. Chelghoum Y, Vey N, Raffoux E, Huguet F, Pigneux A, Witz B, Pautas C, de Botton S, Guyotat D, Lioure B, Fegueux N, Garban F, Saad H, Thomas X (2005) Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 104:110–117. doi: 10.1002/cncr.21137, ReviewPubMedGoogle Scholar
  43. Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804–815. doi: 10.1007/3-540-29933-57 PubMedGoogle Scholar
  44. Chittenden B, Ahamed E, Maheshwari A (2009) Choriocarcinoma in a postmenopausal woman. Obstet Gynecol 114(2 Pt 2):462–465. doi: 10.1097/AOG.0b013e3181aa97e7 PubMedGoogle Scholar
  45. Choi KK, Hong YJ, Choi SB, Park YN, Choi JS, Lee WJ, Kim KS (2011) Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients? J Hepatobiliary Pancreat Sci 18:422–431PubMedGoogle Scholar
  46. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G (2005) Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 190:467–473. doi: 10.1016/j.amjsurg.2005.03.033 PubMedGoogle Scholar
  47. Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, Matifat F (2007) The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol 71:843–851. doi:10.1002/jcp. 21065PubMedGoogle Scholar
  48. Cole S, Kantarijan H, Ault P, Cortès JE (2009) Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma 9:324–327. doi: 10.3816/CLM.2009.n.064 PubMedGoogle Scholar
  49. Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G, Gómez-Graña A, de Cubas AA, Inglada-Pérez L, Maliszewska A, Taschin E, Bobisse S, Pica G, Loli P, Hernández-Lavado R, Díaz JA, Gómez-Morales M, González-Neira A, Roncador G, Rodríguez-Antona C, Benítez J, Mannelli M, Opocher G, Robledo M, Cascón A (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663–667. doi: 10.1038/ng.861 PubMedGoogle Scholar
  50. Cordeiro A, Machado AI, Borges A, Alves MJ, Frade MJ (2009) Burkitt's lymphoma related to Epstein-Barr virus infection during pregnancy. Arch Gynecol Obstet 280(2):297–300Google Scholar
  51. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22:697–714. doi: 10.1007/s10552-011-9742-7 PubMedGoogle Scholar
  52. de Waard F, Thijssen JH (2005) Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. J Steroid Biochem Mol Biol 97:451–458PubMedGoogle Scholar
  53. DeAngelis LM (1994) Central nervous system neoplasms in pregnancy. Adv Neurol 64:139–152PubMedGoogle Scholar
  54. Dessolle L, Dalmon C, Roche B, Darai E (2007) Placental metastases from maternal malignancies: review of the literature (French). J Gynecol Obstet Biol Reprod (Paris) 36:344–353. doi: 10.1016/S1637-4088(07)79644-X Google Scholar
  55. Díaz L, Ceja-Ochoa I, Restrepo-Angulo I, Larrea F, Avila-Chávez E, García-Becerra R, Borja-Cacho E, Barrera D, Ahumada E, Gariglio P, Alvarez-Rios E, Ocadiz-Delgado R, Garcia-Villa E, Hernández-Gallegos E, Camacho-Arroyo I, Morales A, Ordaz-Rosado D, García-Latorre E, Escamilla J, Sánchez-Peña LC, Saqui-Salces M, Gamboa-Dominguez A, Vera E, Uribe-Ramírez M, Murbartián J, Ortiz CS, Rivera-Guevara C, De Vizcaya-Ruiz A, Camacho J (2009) Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression. Cancer Res 69:3300–3307. doi: 10.1158/0008-5472.CAN-08-2036 PubMedGoogle Scholar
  56. Diepstra A, Poppema S, Boot M, Visser L, Nolte IM, Niens M, Te Meerman GJ, van den Berg A (2008) HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma. Tissue Antigens 71:219–226. doi: 10.1111/j.1399-0039.2008.01005.x PubMedGoogle Scholar
  57. Dollar JR, Blackwell RE (1986) Diagnosis and management of prolactinomas. Cancer Metastasis Rev 5:125–138. doi: 10.1007/BF00046427 PubMedGoogle Scholar
  58. Donckier JE, Michel L (2010) Phaeochromocytoma: state-of-the-art. Acta Chir Belg 110:140–148, ReviewPubMedGoogle Scholar
  59. Donegan WL (1983) Cancer and pregnancy. CA Cancer J Clin 33:194–214. doi: 10.3322/canjclin.33.4.194 PubMedGoogle Scholar
  60. Douple EB, Mabuchi K, Cullings HM, Preston DL, Kodama K, Shimizu Y, Fujiwara S, Shore RE (2011) Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med Public Health Prep 5(Suppl 1):S122–S133. doi:10.1001/dmp. 2011.21PubMedGoogle Scholar
  61. Dubernard G, Aractingi S, Oster M, Rouzier R, Mathieu MC, Uzan S, Khosrotehrani K (2008) Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 10.
  62. Dubernard G, Oster M, Chareyre F, Antoine M, Rouzier R, Uzan S, Aractingi S, Khosrotehrani K (2009) Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy. Int J Cancer 124:1054–1059. doi: 10.1002/ijc.24036 PubMedGoogle Scholar
  63. Editorial (1972) Influenza, pregnancy, and leukemia. Br Med J 2:477–478Google Scholar
  64. Emons G, Schroder B, Ortmann O, Westphalen S, Schulz KD, Schally AV (1993) High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 77:1458–1464. doi: 10.1210/jc.77.6.1458 PubMedGoogle Scholar
  65. Even C, Lhommé C, Duvillard P, Morice P, Balleyguier C, Pautier P, Troalen F, de La Motte Rouge T (2011) Ovarian yolk sac tumour: general review. Bull Cancer 98(8):963–975PubMedGoogle Scholar
  66. Farias LMB, Ocaña DB, Díaz L, Larrea F, Avila-Chávez E, Cadena A, Hinojosa LM, Lara G, Villanueva LA, Vargas C, Hernández-Gallegos E, Camacho-Arroyo I, Dueñas-González A, Pérez-Cárdenas E, Pardo LA, Morales A, Taja-Chayeb L, Escamilla J, Sánchez-Peña C, Camacho J (2004) Ether a`go-go potassium channels as human cervical cancer markers. Cancer Res 64:6996–7001. doi: 10.1158/0008-5472.CAN-04-1204 PubMedGoogle Scholar
  67. Freedman WL, McMahon FJ (1960) Placental metastasis. Review of the literature and report of a case of metastatic melanoma. Obstet Gynecol 16:550–560PubMedGoogle Scholar
  68. Freymond N, Cottin V, Cordier JF (2011) Infiltrative lung diseases in pregnancy. Clin Chest Med 32:133–146. doi: 10.1016/j.ccm.2010.11.006, ix. ReviewPubMedGoogle Scholar
  69. Fugazzola L, Cirello V, Beck-Peccoz P (2011) Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol 7:89–97, ReviewPubMedGoogle Scholar
  70. Fukushima K, Ogawa S, Tsukimori K, Kobayashi H, Wake N (2009) Can we diagnose invasive cervical cancer during pregnancy as precise as in nonpregnant women?: maternal and perinatal outcome in pregnancies complicated with cervical cancers. Int J Gynecol Cancer 19:1439–1445. doi: 10.1111/IGC.0b013e3181a83ebf PubMedGoogle Scholar
  71. Füle T, Mathe M, Suba Z et al (2006) The presence of human papillomavirus 16 in neural structures and vascular endothelial cells. Virology 348:289–296. doi: 10.1016/j.virol.2005.12.043 PubMedGoogle Scholar
  72. Gadi VK (2009) Fetal microchimerism and cancer. Cancer Lett 276:8–13. doi: 10.1016/j.canlet.2008.07.025 PubMedGoogle Scholar
  73. Gadi VK (2010) Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 121:241–244. doi: 10.1007/s10549-009-0548-1 PubMedGoogle Scholar
  74. Gadi VK, Nelson JL (2007) Fetal microchimerism in women with breast cancer. Cancer Res 67:9035–9038. doi: 10.1158/0008-5472.CAN-06-4209 PubMedGoogle Scholar
  75. Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL (2008) Case-control study of fetal microchimerism and breast cancer. PLoS One 3:1–5. doi: 10.1371/journal.pone.0001706 Google Scholar
  76. Gambino A, Gorio A, Carrara L, Agoni L, Franzini R, Lupi GP, Maggino T, Romagnolo C, Sartori E, Pecorelli S (2011) Cancer in pregnancy: maternal and fetal implications on decision-making. Eur J Gynaecol Oncol 32:40–45PubMedGoogle Scholar
  77. Gamoudi A, Farhat K, Derouiche S, Hechiche M, Khattech R, Rahal K, Ben Romdhane K (1995) Breast angiosarcoma. Five case reports [Article in French]. Rev Fr Gynecol Obstet 90:435–441. doi: 10.1111/j.1365-2559.1995.tb00329.x PubMedGoogle Scholar
  78. Ganapathi KA, Paczos T, George MD, Goodloe S, Balos LL, Chen F (2010) Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature. Int J Gynecol Pathol 29:476–478. doi: 10.1097/PGP.0b013e3181d81cc2, ReviewPubMedGoogle Scholar
  79. Ginestier C, Wicha MS (2007) Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res 9:109. doi: 10.1186/bcr1741 PubMedGoogle Scholar
  80. Giordano G, Bersiga A, Marchetti G, Melpignano M (2010) Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis. Eur J Gynaecol Oncol 31:211–213PubMedGoogle Scholar
  81. Gissmann L, Boshart M, Dürst M, Ikenberg H, Wagner D, zur Hausen H (1984) Presence of human papillomavirus in genital tumors. J Invest Dermatol 83 (1 Suppl):26s–28s. ReviewGoogle Scholar
  82. Giuntoli RL, Vang RS, Bristow RE (2006) Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol 49:492–505. doi: 10.1097/00003081-200609000-00009 PubMedGoogle Scholar
  83. Gliśić A, Atanackovic J (2006) Kruckenberg tumor in pregnancy.The lethal outcome. Pathol Oncol Res 12:108–110. doi: 10.1007/BF02893454 PubMedGoogle Scholar
  84. Gomez-Garcia L, Sanchez FM, Vallejo-Cremades MT, de Segura IA, del Campo Ede M (2005) Direct activation of telomerase by GH via phosphatidylinositol 3′-kinase. J Endocrinol 185:421–428PubMedGoogle Scholar
  85. Goodman A, Schorge J, Greene MF (2011) The long-term effects of in utero exposures–the DES story. N Engl J Med 364:2083–2084. doi: 10.1056/NEJMp1104409 PubMedGoogle Scholar
  86. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi J-TA, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450:1096–1099. doi: 10.1038/nature05992 PubMedGoogle Scholar
  87. Grzegorczyk V, Brasseur-Daudruy M, Labadie G, Cellier C, Verspyck E (2010) Prenatal diagnosis of a nasal glioma. Pediatr Radiol 40:1706–1709. doi: 10.1007/s00247-010-1642-6 PubMedGoogle Scholar
  88. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318. doi: 10.1080/00313020701329914 PubMedGoogle Scholar
  89. Gucciardo L, Uyttebroek A, De Wever I, Renard M, Claus F, Devlieger R, Lewi L, De Catte L, Deprest J (2011) Prenatal assessment and management of sacrococcygeal teratoma. Prenat Diagn 31:678–688. doi: 10.1002/pd.2781 PubMedGoogle Scholar
  90. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O’Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Eng J Med 8:549–555. doi: 10.1056/NEJM199908193410801 Google Scholar
  91. Hafeez I, Lawenda BD, Schilder JM, Johnstone PA (2011) Prolonged survival after episiotomy recurrence of cervical cancer complicating pregnancy. Eur J Gynaecol Oncol 32:211–213PubMedGoogle Scholar
  92. Hamilton DK, Vance ML, Boulos PT, Laws ER (2005) Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary 8:53–60. doi: 10.1007/s11102-005-5086-1 PubMedGoogle Scholar
  93. Hancock BW, Tidy JA (2002) Current management of molar pregnancy. J Reprod Med 47:347–354PubMedGoogle Scholar
  94. Hannuna KY, Putignani L, Silvestri E, Pisa R, Angioli R, Signore F (2009) Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer 19:1580–1584, ReviewPubMedGoogle Scholar
  95. Harrison CN (2005) Platelets and thrombosis in myeloproliferative diseases. Hematology 1:409–415. doi: 10.1182/asheducation-2005.1.409 Google Scholar
  96. Harrison CN, Robinson SE (2011) Myeloproliferative disorders in pregnancy. Hematol Oncol Clin North Am 25:261–275, vii. ReviewPubMedGoogle Scholar
  97. Hechtman JF, Chepovetsky JA, Strauchen JA, Burstein DE, Beasley MB (2011) Thymomas diagnosed during pregnancy: two cases in young women without paraneoplastic or autoimmune disease. Ann Diagn Pathol. doi: 10.1016/j.anndiagpath.2011.03.003
  98. Hemmerlein B, Weseloh RM, De Queiroz FM, Knötgen H, Sánchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz-Joachim-Radzun, Stühmer W, Pardo LA (2006) Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5:41–53. doi: 10.1186/1476-4598-5-41 PubMedGoogle Scholar
  99. Hernández JL, Gómez-Román J, Ramos-Estébanez C, Martín-Oviedo J, Riancho JA, González-Macías J (2005) Human herpesvirus 8 and Epstein-Barr virus coinfection in localized Castleman disease during pregnancy. Haematologica. 90 Suppl:ECR35Google Scholar
  100. Hill N, Madarnas Y (2011) Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature. Breast Cancer Res Treat 129:265–268. doi: 10.1007/s10549-011-1542-y PubMedGoogle Scholar
  101. Hirsch D, Levy S, Tsvetov G, Weinstein R, Lifshitz A, Singer J, Shraga-Slutzky I, Grozinski-Glasberg S, Shimon I, Benbassat C (2010) Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid 20:1179–1185. doi: 10.1089/thy.2010.0081 PubMedGoogle Scholar
  102. Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84:985–1000. doi: 10.4065/84.11.985 PubMedGoogle Scholar
  103. Holtan SG, Creedon DJ, Thompson MA, Nevala WK, Markovic SN (2011) Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma. Clin Dev Immunol 2011:316314. doi: 10.1155/2011/316314 PubMedGoogle Scholar
  104. Hsiao YH, Deng C, Mason JT, Chou MC, Man YG (2011) Hidden malignant cells within leukocyte aggregates: seeds for invasive and metastatic cancer? Cancer Epidemiol 35(5):475–479. doi:10.1016/j.canep. 2010.11.010PubMedGoogle Scholar
  105. Hsing AW, McLaughin JK, Hoover RN, Co Chien HT, Blot WJ, Fraumeni JF Jr (1992) Parity and 1706 primary liver cancer among young women. J Natl Cancer Inst 84:1118–1119. doi:10.1093/jnci/ 1707 84.14.1118Google Scholar
  106. Hubackova M, Vaclavikova R, Ehrlichova M, Mrhalova M, Kodet R, Kubackova K, Vrána D, Gut I, Soucek P (2011) Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas. Int J Cancer 130(2):338–348. doi: 10.1002/ijc.26006 PubMedGoogle Scholar
  107. Hussein IY, Said MR, Padel A (2010) Unusual presentation of invasive hydatidiform mole metastasizing to the lung. J Obstet Gynaecol 30:748–750. doi: 10.3109/01443615.2010.501413 PubMedGoogle Scholar
  108. Hwang JY, Lin BY, Tang FM, Yu WCY (1992) Tamoxifen stimulates human papillomavirus type 16 gene expression and cell proliferation in a cervical cancer cell line. Cancer Res 52:6848–6852PubMedGoogle Scholar
  109. Iglesias BV, Centeno G, Pascuccelli H, Ward F, Peters MG, Filmus J, Puricelli L, de Kier Joffé EB (2008) Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 23:1333–1340PubMedGoogle Scholar
  110. Illés A, Bányai A, Jenei K, Bacskó G, Kovács J, Szakáll S, Szegedi G (1996) [Bilateral primary lymphoma of the breasts detected in pregnancy]. Orv Hetil. 137(24):1315-7. Review. HungarianGoogle Scholar
  111. Imran SA, Rajaraman M (2011) Management of differentiated thyroid cancer in pregnancy. J Thyroid Res 2011:549609. doi: 10.4061/2011/549609 PubMedGoogle Scholar
  112. Isla A, Alvarez F, Gonzalez A, Garcia-Grande A, Perez-Alvarez M, GarciaBlazquez M (1997) Brain tumor and pregnancy. Obstet Gynecol 89:19–23. doi: 10.1016/S0029-7844(96)00381-X PubMedGoogle Scholar
  113. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C, Hinds PW (2010) Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 17:65–76. doi: 10.1016/j.ccr.2009.11.024 PubMedGoogle Scholar
  114. Jinek M, Fabian MR, Coyle SM, Sonenberg N, Doudna JA (2010) Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation. Nat Struct Mol Biol 17:238–240. doi: 10.1038/nsmb.1768 PubMedGoogle Scholar
  115. Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872. doi: 10.1158/1055-9965.EPI-11-0515 PubMedGoogle Scholar
  116. John AS, Connolly HM, Schaff HV, Klarich K (2011) Management of cardiac myxoma during pregnancy: a case series and review of the literature. Int J Cardiol. doi: 10.1016/j.ijcard.2011.05.069
  117. Jønsson V, Tjønnfjord GE, Johannesen TB, Samuelsen SO, Ly B (2008) Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders. Transl Oncogenomics 3:15–20. doi: 10.1080/10428190701713705 PubMedGoogle Scholar
  118. Kallenbach LR, Johnson KL, Bianchi DW (2011) Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology. Cancer Res 71:8–12. doi: 10.1158/0008-5472.CAN-10-0618, ReviewPubMedGoogle Scholar
  119. Kara T, Ozcan Kara P, Baba F, Celik C, Kara Gedik G (2011) Primary epithelioid trophoblastic tumor with a synchronize breast carcinoma detected only with FDG-PET/CT Scan. Rev Esp Med Nucl 30(6):368–371PubMedGoogle Scholar
  120. Kars M, Dekkers OM, Pereira AM, Romijn JA (2010) Update in prolactinomas. Neth J Med 68:104–112PubMedGoogle Scholar
  121. Kasenda B, Rückert A, Farthmann J, Schilling G, Schnerch D, Prömpeler H, Wäsch R, Engelhardt M (2011) Management of multiple myeloma in pregnancy: strategies for a rare challenge. Clin Lymphoma Myeloma Leuk 11:190–197. doi: 10.1016/j.clml.2011.03.009 PubMedGoogle Scholar
  122. Keleher A, Wendt R III, Delpassand E, Stachowiak AM, Kuerer HM (2004) The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99 m sulfur colloid. Breast J 10:492–495. doi: 10.1111/j.1075-122X.2004.21503.x PubMedGoogle Scholar
  123. Khatib F, Shaya M, Samueloff A (2003) Gastric carcinoma with metastasis to the placenta and amniotic fluid: case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 107:208–209. doi: 10.1016/S0301-2115(02)00261-0 PubMedGoogle Scholar
  124. Khosrotehrani K, Aractingi S (2009) Fetal cell microchimerism in cancer: a meaningful event? Future Oncol 5:1441–1448. doi: 10.2217/fon.09.111 PubMedGoogle Scholar
  125. Khosrotehrani K, Nguyen Huu S, Prignon A, Avril MF, Boitier F, Oster M, Mortier L, Richard MA, Maubec E, Kerob D, Mansard S, Merheb C, Moguelet P, Nassar D, Guégan S, Aractingi S (2011) Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol 178:1870–1880. doi: 10.1016/j.ajpath.2010.12.044 PubMedGoogle Scholar
  126. Kinugasa-Taniguchi Y, Ueda Y, Hara-Ohyagi C, Enomoto T, Kanagawa T, Kimura T (2011) Impaired delivery outcomes in pregnancies following myomectomy compared to myoma-complicated pregnancies. J Reprod Med 56:142–148PubMedGoogle Scholar
  127. Koskas M, Morice P, Yazbeck C, Duvillard P, Walker F, Madelenat P (2009) Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence. Anticancer Res 29:4147–4150PubMedGoogle Scholar
  128. Kulka J, Kovalszky I, Svastics E, Berta M, Füle T (2008) Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Hum Pathol 39:298–301. doi: 10.1016/j.humpath.2007.08.006 PubMedGoogle Scholar
  129. Kumar J, Llancheran A, Ratnam SS (1988) Pulmonary metastases in gestational trophoblastic disease: a review of 97 cases. Br J Obstet Gynaecol 95:70–74. doi: 10.1111/j.1471-0528.1988.tb06482.x PubMedGoogle Scholar
  130. Kuyumcuoglu U, Guzel AI, Erdemoglu M, Celik Y (2011) Risk factors for persistent gestational trophoblastic neoplasia. J Exp Ther Oncol 9:81–84PubMedGoogle Scholar
  131. Ladányi A, Mohos A, Somlai B, Liszkay G, Gilde K, Fejős K, Gaudi I, Tímár J (2010) FOXP3 + cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathol Oncol Res 16:303–309. doi: 10.1007/s12253-010-9254-x PubMedGoogle Scholar
  132. Lagiou P, Samoli E, Okulicz W, Xu B, Lagiou A, Lipworth L, Georgila C, Vatten L, Adami HO, Trichopoulos D, Hsieh CC (2011) Maternal and cord blood hormone levels in the United States and China and the intrauterine origin of breast cancer. Ann Oncol 22:1102–1108. doi: 10.1093/annonc/mdq565 PubMedGoogle Scholar
  133. Lam JS, Breda A, Belldegrun AS, Figlin RA (2006) Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. J Clin Oncol. 24(35):5565–75. ReviewGoogle Scholar
  134. Lambrechts S, Van Calsteren K, Capoen A, Op de Beeck K, Joniau S, Timmerman D, Amant F (2011) A case of polypoïd endometriosis of the bladder during pregnancy mimicking urachal carcinoma. Ultrasound Obstet Gynecol 38(4):475–478. doi: 10.1002/uog.8985 PubMedGoogle Scholar
  135. Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Björkholm M (2008) Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood 112:2199–2204. doi: 10.1182/blood-2008-03-143602 PubMedGoogle Scholar
  136. Langagergaard V (2011) Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review. Clin Epidemiol 3:7–19. doi: 10.2147/CLEP.S12190 Google Scholar
  137. Langagergaard V, Horvath-Puho E, Nørgaard M, Nørgård B, Sørensen HT (2008) Hodgkin’s disease and birth outcome: a Danish nationwide cohort study. Br J Cancer 98:183–188. doi: 10.1038/sj.bjc.6604126 PubMedGoogle Scholar
  138. Langevin SM, Grandis JR, Taioli E (2011) Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk. Cancer Lett 310(2):216–221. doi: 10.1016/j.canlet.2011.07.007 PubMedGoogle Scholar
  139. Larfors G, Höglund M, Cnattingius S (2011) Pregnancy and risk of acute myeloid leukaemia—a case-control study. Eur J Haematol 87:169–171. doi: 10.1111/j.1600-0609.2011.01643.x PubMedGoogle Scholar
  140. Lau WY, Leung WT, Ho S, Lam SK, Li CY, Johnson PJ, Williams R, Li AK (1995) Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer 75:2669–2676. doi:10.1002/1097-0142(19950601)75:11<2669::AID-CNCR2820751105>3.0.CO;2-BPubMedGoogle Scholar
  141. Le A, Shan L, Yuan R, Liu Z, Yang H, Wang Z (2011) Primary fallopian tube cancer in term pregnancy: a case report. Eur J Gynaecol Oncol 32:208–210PubMedGoogle Scholar
  142. Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR (2001) Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 97:965–970. doi: 10.1016/S0029-7844(01)01131-0 PubMedGoogle Scholar
  143. Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PSF, Lau EMC, Wong C-M (2002) Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an ageperiod-cohort analysis. Br J Cancer 87:982–988. doi: 10.1038/sj.bjc.6600583 PubMedGoogle Scholar
  144. Li J, Wang LJ, Zhang BZ, Peng YP, Lin ZQ (2011a) Neoadjuvant chemotherapy with paclitaxel plus platinum for invasive cervical cancer in pregnancy: two case report and literature review. Arch Gynecol Obstet 284(3):779–783. doi: 10.1007/s00404-011-1943-5 PubMedGoogle Scholar
  145. Li X, Zhang Y, Shi Y, Dong D, Liang J, Han Y, Wang X, Zhao Q, Ding J, Wu K, Fan D (2011b) MicroRNA-107, an oncogene MicroRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 15(9):1887–1895. doi: 10.1111/j.1582-4934.2010.01194.x PubMedGoogle Scholar
  146. Liang DC, Shih LY, Yang CP, Hung IJ, Liu HC, Jaing TH, Yeh TC, Liang ST, Chang CL, Lee EH, Lai CL, Chang WH (2010) Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west. Pediatr Blood Cancer 55:430–433. doi: 10.1002/pbc.22628 PubMedGoogle Scholar
  147. Lucenteforte E, Zucchetto A, Bosetti C, Talamini R, Negri E, Serraino D, Franceschi S, Lipworth L, La Vecchia C (2011) Reproductive and hormonal factors and pancreatic cancer risk in women. Pancreas 40:460–463. doi: 10.1097/MPA.0b013e31820bf986 PubMedGoogle Scholar
  148. Luense LJ, Carletti MZ, Christenson LK (2009) Role of Dicer in female fertility. Trends Endocrinol Metab 20:265–272. doi: 10.1016/j.tem.2009.05.001, ReviewPubMedGoogle Scholar
  149. Lynch HT, Shaw TG, Lynch JF (2004) Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 129C:5–22. doi: 10.1002/ajmg.c.30026 PubMedGoogle Scholar
  150. Ma Y, Zhang P, Wang F, Yang J, Yang Z, Qin H (2010) The relationship between early embryo development and tumourigenesis. J Cell Mol Med 14(12):2697–2701. doi: 10.1111/j.1582-4934.2010.01191.x., ReviewPubMedGoogle Scholar
  151. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221PubMedGoogle Scholar
  152. Mahmoud HH, Ridge SA, Behm FG, Pui CH, Ford AM, Raimondi SC, Greaves MF (1995) Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. Med Pediatr Oncol 24:77–81. doi: 10.1002/mpo.2950240203 PubMedGoogle Scholar
  153. Marshall NA, Culligan DJ, Thige J, Johnston PW, Barker RN, Vickers MA (2007) íthe relationships between Epstein-Barr virus latent membrane protein 1 and regolatory T cells in Hodgkin’s lymphoma. Exp Hematol 35:596–604. doi: 10.1016/j.exphem.2007.01.030 PubMedGoogle Scholar
  154. Mazur MT, Lurain JR, Brewer JI (1982) Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center. Cancer 50:1833–1846. doi:10.1002/1097-0142(19821101)50:9<1833::AID-CNCR2820500930>3.0.CO;2-4PubMedGoogle Scholar
  155. Melbye M, Wohlfahrt J, Lei U, Nørgaard-Pedersen B, Mouridsen HT, Lambe M, Michels KB (2000) Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 92:1001–1005. doi: 10.1093/jnci/92.12.1001 PubMedGoogle Scholar
  156. Melillo L, Tieghi A, Candoni A, Radaelli F, Ciancia R, Specchia G, Martino B, Scalzulli PR, Latagliata R, Palmieri F, Usala E, Valente D, Valvano MR, Cedrone M, Comitini G, Martinelli V, Cascavilla N, Gugliotta L (2009) Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol 84:636–640. doi: 10.1002/ajh.21504 PubMedGoogle Scholar
  157. Memarzadeh S, Zong Y, Janzen DM, Goldstein AS, Cheng D, Kurita T, Schafenacker AM, Huang J, Witte ON (2010) Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proc Natl Acad Sci U S A 107:17298–17303. doi: 10.1073/pnas.1012548107 PubMedGoogle Scholar
  158. Menada MV, Moioli M, Garaventa A, Nozza P, Foppiano M, Trimarchi N, Fulcheri E (2010) Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature. Melanoma Res 20:443–449. doi: 10.1111/j.1600-0625.2006.00502.x Google Scholar
  159. Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sánchez MJ, Rodríguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562–2569. doi: 10.1158/1055-9965.EPI-10-0447 PubMedGoogle Scholar
  160. Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:622–635. doi: 10.1067/moe.2001.115392 PubMedGoogle Scholar
  161. Minig L, Franchi D, Boveri S, Casadio C, Bocciolone L, Sideri M (2011) Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol 22:643–649. doi: 10.1093/annonc/mdq463 PubMedGoogle Scholar
  162. Mirra AP, Cole P, MacMahon B (1971) Breast cancer in an area of high parity: São Paulo, Brazil. Cancer Res 31:77–83PubMedGoogle Scholar
  163. Miyoshi I, Yamamoto K, Saito T, Taguchi H (2006) Burkitt lymphoma of the breast. Am J Hematol. 81(2):147–148Google Scholar
  164. Molitch ME (2010) Prolactinomas and pregnancy. Clin Endocrinol (Oxf) 73:147–148. doi: 10.1111/j.1365-2265.2010.03823.x Google Scholar
  165. Moreira WB, Brandão EC, Soares AN, Lucena CE, Antunes CM (2010) Prognosis for patients diagnosed with pregnancy-associated breast cancer: a paired case-control study. Sao Paulo Med J 128(3):119–124. doi: org/10.1590/S1516-31802010000300003 PubMedGoogle Scholar
  166. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S, International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359:1085–1092. doi: 10.1016/S0140-6736(02)08150-3 PubMedGoogle Scholar
  167. Moussaoui CL, Khaled H, Fehri HS, Jalil A, Souadka A, Alaoui MT, Gueddari B (2003) Breast angiosarcomas: three case reports. Ann Chir 128:43–48PubMedGoogle Scholar
  168. Murphy LC, Seekallu SV, Watson PH (2011) Clinical significance of estrogen receptor phosphorylation. Endocr Relat Cancer 18:R1–R14. doi: 10.1677/ERC-10-0070, ReviewPubMedGoogle Scholar
  169. Musashi M, Syuiti A, Yamada T, Tanaka J, Gothonda Y, Maeda S, Sato Y, Morioka M, Skurada K, Minagawa T, Asaka M, Miyazaki T (1997) Spontaneous remission in a patient with chronic myelogenous leukemia. N Engl J Med 336:337–339. doi: 10.1056/NEJM199701303360504 PubMedGoogle Scholar
  170. Myal Y, Leygue E, Blanchard AA (2010) Claudin 1 in breast tumorigenesis: revelation of a possible novel “claudin high” subset of breast cancers. J Biomed Biotechnol 2010:956897. doi: 10.1155/2010/956897 PubMedGoogle Scholar
  171. Nair HB, Luthra R, Kirma N, Liu YG, Flowers L, Evans D, Tekmal RR (2005) Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res 65:11164–11173. doi: 10.1158/0008-5472.CAN-05-1087 PubMedGoogle Scholar
  172. Naugler WE, Sakurai T, Kim S, Kim KH, Maeda S, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88- dependent IL-6 production. Science 317:121–124PubMedGoogle Scholar
  173. Noreen H, Syed S, Chaudhri R, Kahloon LE (2011) A large unilocular mucinous cystadenoma in third trimester of pregnancy. J Coll Physicians Surg Pak 21:426–428PubMedGoogle Scholar
  174. Novac L, Niculescu M, Manolea MM, Iliescu D, Georgescu CV, Comănescu A, Cernea N, Enache A (2011) The vasculogenesis—a possible histological identification criterion for the molar pregnancy. Rom J Morphol Embryol 52:61–67PubMedGoogle Scholar
  175. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE (2001) Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 16:855–861. doi: 10.1093/humrep/16.5.855 PubMedGoogle Scholar
  176. O’Donoghue K, Sultan HA, Al-Allaf FA, Anderson JR, Wyatt-Ashmead J, Fisk NM (2008) Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online 16:382–390PubMedGoogle Scholar
  177. Oliva R, Angelos P, Kaplan E, Bakris G (2010) Pheochromocytoma in pregnancy: a case series and review. Hypertension 55:600–606. doi: 10.1161/HYPERTENSIONAHA.109.147579, ReviewPubMedGoogle Scholar
  178. Osada S, Horibe K, Oiwa K, Yoshida J, Iwamura H, Matsuoka H, Adachi K, Morishima Y, Ohno R, Ueda R, Utsumi KR (1990) A case of infantile acute monocytic leukemia caused by vertical transmission of the mother’s leukemic cells. Cancer 65:1146–1149. doi:10.1002/1097-0142(19900301)65:5<1146::AID-CNCR2820650519>3.0.CO;2-JPubMedGoogle Scholar
  179. Osipo C, Gajdos C, Liu H, Chen B, Jordan VC (2003) Paradoxical actions of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer. J Natl Cancer Inst 95:1597–1608. doi: 10.1093/jnci/djg079 PubMedGoogle Scholar
  180. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y (2011) MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 6(1):e16617. doi: 10.1371/journal.pone.0016617 PubMedGoogle Scholar
  181. Ouazzani A, de Fontaine S, Berthe JV (2007) Extracranial meningioma and pregnancy: a rare diagnosis. J Plast Reconstr Aesthet Surg 60:622–625. doi: 10.1016/j.bjps.2006.01.054 PubMedGoogle Scholar
  182. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, Bubendorf L, Kunzelmann K, Schreiber R (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13:824–831. doi: 10.1158/1078-0432.CCR-06-1940 PubMedGoogle Scholar
  183. Pallud J, Mandonnet E, Deroulers C, Fontaine D, Badoual M, Capelle L, Guillet-May F, Page P, Peruzzi P, Jouanneau E, Frenay M, Cartalat-Carel S, Duffau H, Taillandier L, Club de Neuro-Oncologie de la Société Française de Neurochirurgie (SFNC), Association des Neuro-Oncologues d’Expression Française (ANOCEF) (2010) Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol 67:398–404PubMedGoogle Scholar
  184. Parkin DM, Pisani P, Munoz N, Ferlay J (1999) The global health burden of infection associated cancers. Cancer Surv 49:5–33. doi: 10.3322/canjclin.49.1.33 Google Scholar
  185. Parry EJ, Stevens SR, Gilliam AC, Horvath N, el-Charif M, Spiro TP, Adler LP, Shina D, Kinsella T, Heyman EN, Cooper KD, Wood GS (1999) Management of cutaneous lymphomas using a multidisciplinary approach. Arch Dermatol. 135(8):907–911. ReviewGoogle Scholar
  186. Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist. 7(4):279–287. ReviewGoogle Scholar
  187. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE (2002) Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 11:361–368PubMedGoogle Scholar
  188. Perri T, Korach J, Gotlieb WH, Beiner M, Meirow D, Friedman E, Ferenczy A, Ben-Baruch G (2011) Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved. Int J Gynecol Cancer 21:72–78. doi: 10.1097/IGC.0b013e31820003de PubMedGoogle Scholar
  189. Perry JK, Mohankumar KM, Emerald BS, Mertani HC, Lobie PE (2008) The contribution of growth hormone to mammary neoplasia. J Mammary Gland Biol Neoplasia 13:131–145. doi: 10.1007/s10911-008-9070-z PubMedGoogle Scholar
  190. Pettersson BF, Andersson S, Hellman K, Hellström AC (2010) Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience. Cancer 116:2343–2349. doi: 10.1002/cncr.24971 PubMedGoogle Scholar
  191. Phupong V, Witoonpanich P, Snabboon T, Tharavej C, Ultchaswadi P (2005) Bilateral pheochromocytoma during pregnancy. Arch Gynecol Obstet 271:276–279. doi: 10.1007/s00404-004-0654-6 PubMedGoogle Scholar
  192. Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF (2008) The effects of imatinib on pregnancy outcome. Blood 111:5505–5508. doi: 10.1182/blood-2007-10-114900 PubMedGoogle Scholar
  193. Rajaraman P, Simpson J, Neta G, de Gonzalez AB, Ansell P, Linet MS, Ron E, Roman E (2011) Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. BMJ 342:472. doi: 10.1136/bmj.d472 Google Scholar
  194. Raso A, Mascelli S, Nozza P, Biassoni R, Negri F, Garaventa A, Tarantino V, Garrè ML, Cama A, Capra V (2010) Detection of transplacental melanoma metastasis using quantitative PCR. Diagn Mol Pathol 19:78–82. doi: 10.1097/PDM.0b013e3181b6a546 PubMedGoogle Scholar
  195. Ratajczak MZ, Kucia M, Dobrowolska H, Wanzeck J, Reca R, Ratajczak J (2006) Emerging concept of cancer as a stem cell disorder. Cent Eur J Biol 1:73–87. doi: 10.2478/s11535-006-0006-6 Google Scholar
  196. Razak AR, Nasser Q, Morris P, Alcutt D, Grogan L (2005) Medulloblastoma in two successive pregnancies. J Neurooncol 73:89–90. doi: 10.1007/s11060-004-4209-2 PubMedGoogle Scholar
  197. Reynolds AG (1955) Placental metastasis from malignant melanoma; report of a case. Obstet Gynecol 6:205–209PubMedGoogle Scholar
  198. Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE, Calvin JA (1998) Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol. 148(8):719–727Google Scholar
  199. Rigby PG, Hanson TA, Smith RS (1964) Passage of leukemic cells across the placenta. N Engl J Med 271:124–127. doi: 10.1056/NEJM196407162710304 PubMedGoogle Scholar
  200. Rigourd V, Chauvet C, Chelbi ST, Rebourcet R, Mondon F, Letourneur F, Mignot TM, Barbaux S, Vaiman D (2008) STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS One 3:e3905. doi: 10.1371/journal.pone.0003905 PubMedGoogle Scholar
  201. Ring AE, Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE, Calvin JA (1998) Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 148:719–727Google Scholar
  202. Rollison DE, Helzlsouer KJ, Lee J-H, Fulp W, Clipp S, Hoffman-Bolton JA, Giuliano AR, Platz EA, Viscidi RP (2009) Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev 18:1515–1523. doi: 10.1158/1055-9965.EPI-08-1119 PubMedGoogle Scholar
  203. Roth P, Junker M, Tritschler I, Mittelbronn M, Dombrowski Y, Breit SN, Tabatabai G, Wick W, Weller M, Wischhusen J (2010) GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin Cancer Res 16:3851–3859. doi: 10.1158/1078-0432.CCR-10-0705 PubMedGoogle Scholar
  204. Saikali Z, Sinnett D (2000) Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer 89:418–422. doi:10.1002/1097-0215(20000920)89:5<418::AID-IJC4>3.3.CO;2-9PubMedGoogle Scholar
  205. Saini R, Khim TP, Rahman SA, Ismail M, Tang TH (2010) High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children. High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children. Virol J 7:131. doi: 10.1186/1743-422X-7-131 PubMedGoogle Scholar
  206. Salahshor S, Goncalves J, Chetty R, Gallinger S, Woodgett JR (2005) Differential gene expression profile reveals deregulation of pregnancy specific β1 glycoprotein 9 early during colorectal carcinogenesis. BMC Cancer 5:66. doi: 10.1186/1471-2407-5-66 PubMedGoogle Scholar
  207. Samarnthai N, Hall K, Yeh IT (2010) Molecular profiling of endometrial malignancies. Obstet Gynecol Int 2010(162363). doi: 10.1155/2010/162363
  208. Santin AP, Furlanetto TW (2011) Role of estrogen in thyroid function and growth regulation. J Thyroid Res 2011(875125). doi: 10.4061/2011/875125
  209. Sanz MA, Grimwade D, Tallman MS et al (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood 113:1875–1891. doi: 10.1182/blood-2008-04-150250 PubMedGoogle Scholar
  210. Savarese TM, Strohsnitter WC, Low HP, Liu Q, Baik I, Okulicz W, Chelmow DP, Lagiou P, Quesenberry PJ, Noller KL, Hsiehet C-C (2007) Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res 9:R29. doi: 10.1186/bcr1674 PubMedGoogle Scholar
  211. Schmidt A, Nanney LB, Boyd AS, King LE Jr, Ellis DL (2006) Oestrogen receptor expression in melanocytic lesions. Exp Dermatol 15:971–980. doi: 10.1111/j.1600-0625.2006.00502.x PubMedGoogle Scholar
  212. Sekine S, Ogawa R, Ito R, Hiraoka N, McManus MT, Kanai Y, Hebrok M (2009) Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 136:2304–2315. doi: 10.1053/j.gastro.2009.02.067 PubMedGoogle Scholar
  213. Sgarbi JA, Kasamatsu TS, Matsumura LK, Maciel RM (2010) Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid 20:1151–1156. doi: 10.1089/thy.2009.0424 PubMedGoogle Scholar
  214. Shapira T, Pereg D, Lishner M (2008) How I treat acute and chronic leukemia in pregnancy. Blood Rev 22:247–259. doi: 10.1016/j.blre.2008.03.006 PubMedGoogle Scholar
  215. Shih IeM (2007) Gestational trophoblastic neoplasia-pathogenesis and potential therapeutic targets. Lancet Oncol 8:642–650. doi: 10.1016/S1470-2045(07)70204-8 PubMedGoogle Scholar
  216. Siddon A, Hui P (2010) Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin. Int J Gynecol Pathol 29:394–397. doi: 10.1097/PGP.0b013e3181c5a7e8 PubMedGoogle Scholar
  217. Sierra-Bergua B, Sánchez-Marteles M, Cabrerizo-García JL, Sanjoaquin-Conde I (2008) Choriocarcinoma with pulmonary and cerebral metastases. Singapore Med J 49:e286–e288PubMedGoogle Scholar
  218. Sinkovics JG (1991) Hodgkin’s Disease revisited: reed-sternberg cells as natural hybridomas. Crit Rev Immunol 11:33–63PubMedGoogle Scholar
  219. Sinkovics JG, Drewinko B, Thornell E (1970) Immunoresistant tetraploid lymphomacells. Lancet 1:139–140PubMedGoogle Scholar
  220. Sioka C, Fotopoulos A (2011) Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril 95:1552–1559. doi: 10.1016/j.fertnstert.2011.01.017, ReviewPubMedGoogle Scholar
  221. Sirotkin AV, Ovcharenko D, Grossmann R, Lauková M, Mlynčeket M (2009) Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J Cell Physiol 219:415–420. doi:10.1002/jcp. 21689PubMedGoogle Scholar
  222. Slim R, Mehio A (2007) The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet 71:25–34. doi: 10.1111/j.1399-0004.2006.00697.x PubMedGoogle Scholar
  223. Small W Jr, Lurain JR, Shetty RM, Huang CF, Applegate GL, Brand WN (1996) Gestational trophoblastic disease metastatic to the brain. Radiology 200:277–280PubMedGoogle Scholar
  224. Smith IF, Skelton V (2007) An unusual intracranial tumour presenting in pregnancy. Int J Obstet Anesth 16:82–85. doi: 10.1016/j.ijoa.2006.04.016 PubMedGoogle Scholar
  225. Smith LH, Danielsen B, Allen ME, Cress R (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189:1128–1135. doi: 10.1067/S0002-9378(03)00537-4 PubMedGoogle Scholar
  226. Smith IE, Jones A, Shannon C, Galani E, Ellis PA (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23:4192–4197. doi: 10.1200/JCO.2005.03.038 PubMedGoogle Scholar
  227. Soundararajan R, Rao AJ (2004) Trophoblast ‘pseudotumorigenesis’: significance and contributory factors. Reprod Biol Endocrinol 2:15. doi: 10.1186/1477-7827-2-15 PubMedGoogle Scholar
  228. Spits C, De Rycke M, Van Ranst N, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K (2007) Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat Diagn 27:447–456. doi: 10.1002/pd.1708 PubMedGoogle Scholar
  229. Stensheim H, Møller B, van Dijk T, Fosså SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27:45–51. doi: 10.1200/JCO.2008.17.4110 PubMedGoogle Scholar
  230. Strobel ES, Fritschka E (2002) Hereditary premenopausal breast cancer. Onkologie 25:24–27. doi: 10.1159/000055198, ReviewPubMedGoogle Scholar
  231. Stroup AM, Harlan LC, Trimble EL (2008) Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 108:577–583. doi: 10.1016/j.ygyno.2007.11.011 PubMedGoogle Scholar
  232. Sukumvanich P (2011) Review of current treatment options for pregnancy-associated breast cancer. Clin Obstet Gynecol 54:164–172. doi: 10.1097/GRF.0b013e3182083a44, ReveiwPubMedGoogle Scholar
  233. Swearingen B, Biller BMK (2008) Diagnosis and management of pituitary disorders. Contemporary endocrinology. Humana Press, Totowa, doi:  10.1007/978-1-59745-264-9 Google Scholar
  234. Swerdlow SH (2008) WHO classification of tumours of haemopoietic and lymphoid tissues. WHO classification of tumours version 2.2. IARC, LyonGoogle Scholar
  235. Szentirmay Z, Pólus K, Tamás L, Szentkuti G, Kurcsics J, Csernák E, Tóth E, Kásler M (2005) Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev 24:19–34. doi: 10.1007/s10555-005-5045-3, ReviewPubMedGoogle Scholar
  236. Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG (2011) 18 F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 52:1035–1040. doi: 10.2967/jnumed.110.085381 PubMedGoogle Scholar
  237. Tefferi A, Vardiman JW (2008) Classification and diagnosis of myeloproliferative neoplasm: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22:2118–2119Google Scholar
  238. Thieblemont C, Davi F, Noguera ME, Brière J (2011) Non-MALT marginal zone lymphoma. Curr Opin Hematol 18:273–279. doi: 10.1097/MOH.0b013e3283477815 PubMedGoogle Scholar
  239. Tidy JA, Rustin GJ, Newlands ES, Foskett M, Fuller S, Short D, Rowdenet P (1995) Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J ObstetGynaecol 102:715–719. doi: 10.1111/j.1471-0528.1995.tb11429.x Google Scholar
  240. Titus-Ernstoff L, Troisi R, Hatch EE, Hyer M, Wise LA, Palmer JR, Kaufman R, Adam E, Noller K, Herbst AL, Strohsnitter W, Cole BF, Hartge P, Hoover RN (2008) Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology 19:251–257PubMedGoogle Scholar
  241. Titus-Ernstoff L, Troisi R, Hatch EE, Palmer JR, Hyer M, Kaufman R, Adam E, Noller K, Hoover RN (2010) Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl 33:377–384. doi: 10.1111/j.1365-2605.2009.01010.x PubMedGoogle Scholar
  242. Trapeznikov NN, Khasanov SR, Yavorsky VV (1987) Skin melanoma and pregnancy. Russ Vopr Onkol 33:40–46Google Scholar
  243. Travis WD, Brambilla EH, Muller-Hermelink HK, Harris CC (eds) (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart, World Health Organization (WHO) classification of tumors. IARC Press, Lyon, France, pp 152–166Google Scholar
  244. Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:939–940. doi: 10.1016/0140-6736(90)91000-Z PubMedGoogle Scholar
  245. Várkonyi T, Nagy B, Füle T, Tarca AL, Karászi K, Schönléber J, Hupuczi P, Mihalik N, Kovalszky I, Rigó J Jr, Meiri H, Papp Z, Romero R, Than NG (2011) Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 32(Suppl):S21–S29. doi: 10.1016/j.placenta.2010.04.014 PubMedGoogle Scholar
  246. Verloop J, van Leeuwen FE, Helmerhorst TJ, van Boven HH, Rookus MA (2010) Cancer risk in DES daughters. Cancer Causes Control 21:999–1007. doi: 10.1007/s10552-010-9526-5 PubMedGoogle Scholar
  247. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S, Maggiolini M (2006a) 17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol Pharmacol 70:1414–1423PubMedGoogle Scholar
  248. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M (2006b) The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631–646. doi: 10.1210/me.2005-0280 PubMedGoogle Scholar
  249. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-FPubMedGoogle Scholar
  250. Walkington L, Webster J, Hancock BW, Everard J, Coleman RE (2011) Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease. Br J Cancer 104:1665–1669. doi: 10.1038/bjc.2011.139 PubMedGoogle Scholar
  251. Walter BA, Gómez-Macias G, Valera VA, Sobel M, Merino MJ (2011) miR-21 expression in pregnancy-associated breast cancer: a possible marker of poor prognosis. J Cancer 2:67–75PubMedGoogle Scholar
  252. Wang XY, Jakowski J, Tawfik OW, Thomas PA, Fan F (2009a) Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years. Ann Diagn Pathol 13:147–150. doi: 10.1016/j.anndiagpath.2009.02.001 PubMedGoogle Scholar
  253. Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D, Allan RW, Molberg KH, Li J, Cao D (2009b) Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol 33:1529–1539. doi: 10.1097/PAS.0b013e3181ad25d5 PubMedGoogle Scholar
  254. Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ (2005) Aromatase inhibitors in human lung cancer therapy. Cancer Res 65:11287–11291. doi: 10.1158/0008-5472.CAN-05-2737 PubMedGoogle Scholar
  255. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502–506. doi: 10.1056/NEJM198902233200806 PubMedGoogle Scholar
  256. Wernli KJ, WangY ZY, Potter JD, Newcomb PA (2009) The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt) 18:995–1001. doi: 10.1089/jwh.2008.1068 Google Scholar
  257. Woods JB, Martin JN Jr, Ingram FH, Odom CD, Scott-Conner CEH, Rhodes RS (1992) Pregnancy complicated by carcinoma of the colon above the rectum. Am J Perinatol 9:102–110. doi: 10.1055/s-2007-994680 PubMedGoogle Scholar
  258. Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, Kwon EK, Muranski P, Restifo NP, Antony PA (2010) Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 207:651–667. doi: 10.1084/jem.20091921 PubMedGoogle Scholar
  259. Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100. doi: 10.1016/S1470-2045(07)70377-7 PubMedGoogle Scholar
  260. Xue F, Hilakivi-Clarke LA, Maxwell GL, Hankinson SE, Michels KB (2008) Infant feeding and the incidence of endometrial cancer. Cancer Epidemiol Biomarkers Prev 17:1316–1321. doi: 10.1158/1055-9965.EPI-08-0108 PubMedGoogle Scholar
  261. Yan L, Tian Y, Fu Y, Zhao X (2010) Successful pregnancy after fertility-preserving surgery for endometrial stromal sarcoma. Fertil Steril 93:46–49. doi: 10.1016/j.fertnstert.2009.09.024 Google Scholar
  262. Youn SH, Lee YW, Seung NR, Park EJ, Cho HJ, Kim KH, Kim KJ (2010) Rapidly progressing malignant melanoma influenced by pregnancy. Int J Dermatol 49:1318–1320. doi: 10.1111/j.1365-4632.2009.04418.x PubMedGoogle Scholar
  263. Younes SA, Csire M, Palyi B, Mikala G, Vályi-Nagy I, Cseh I, Benczik M, Jeney C, Takács T, Simon E, Fülöp V, Berencsi G, Fekete G, Visy M (2007) Endotoxins do not influence transplacental transmission of lymphotropic human herpesviruses and human papillomaviruses into amniotic fluid taken from healthy mothers before parturition in Hungary. Acta Microbiol Immunol Hung 54:279–303. doi: 10.1556/AMicr.54.2007.3.4 PubMedGoogle Scholar
  264. Younes AS, Csire M, Kapusinszky B, Szomor K, Takács M, Berencsi Gy (2009) Heterogeneous pathways of maternal-fetal transmission of human viruses (review). Pathol Oncol Res 15:451–465. doi: 10.1007/s12253-009-9166-9 PubMedGoogle Scholar
  265. Young RH, Dudley AG, Scully RE (1984) Granulosa cell, sertoli-leydig, and unclassified sex cord-stromal tumors associated with pregnancy: a clinicopathological analysis of 36 cases. Gynecol Oncol 18:181–205PubMedGoogle Scholar
  266. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166:781–787. doi: 10.1016/0020-7292(92)90687-E PubMedGoogle Scholar
  267. Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J, van de Water B (2011a) Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res 13:R52. doi: 10.1186/bcr2883 PubMedGoogle Scholar
  268. Zhang N, Li X, Tao K, Jiang L, Ma T, Yan S, Yuan C, Moran MS, Liang F, Haffty BG, Yang Q (2011b) BCL-2 (−938 C > A) polymorphism is associated with breast cancer susceptibility. BMC Med Genet 12:48. doi: 10.1186/1471-2350-12-48 PubMedGoogle Scholar
  269. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730–755PubMedGoogle Scholar
  270. Zivanović A, Dimitrijević A, Kastratović T, Djurić J, Stanković V, Tanasković I (2011) Ovarian endometroid adenocarcinoma in pregnancy. Vojnosanit Pregl 68:181–184PubMedGoogle Scholar
  271. Zwischenberger BA, Boren T (2010) Placental site trophoblastic tumor presenting as a friable cervical mass. Eur J Gynaecol Oncol 31:570–572PubMedGoogle Scholar
  272. Zynger DL, Gupta A, Luan C, Chou PM, Yang GY, Yang XJ (2008a) Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol 39:224–230. doi: 10.1016/j.humpath.2007.06.006 PubMedGoogle Scholar
  273. Zynger DL, Everton MJ, Dimov ND, Chou PM, Yang XJ (2008b) Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol 130:224–230. doi: 10.1309/8DN7DQRDFB4QNH3N PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Division of VirologyNational Center for EpidemiologyBudapestHungary

Personalised recommendations